Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs SPXU✓SelectedUSD · SPXUGSK vs SPXU performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs SPXU

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.7%
SPXU return
-82.5%
Excess return
+129.1%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioSPXUExcessAlpha
1D-0.1%+5.7%-5.8%+0.5%
7D-1.3%+5.1%-6.4%-0.8%
30D+2.7%+8.5%-5.8%+3.8%
3M+2.7%+15.1%-12.4%+4.5%
6M+3.3%-0.4%+3.8%+3.7%
YTD+6.5%-21.6%+28.1%+4.4%
1Y+10.7%-25.0%+35.6%+8.1%
3Y+64.4%-77.9%+142.3%+42.9%
5Y+46.7%-82.2%+128.9%+28.5%
All+46.7%-82.5%+129.1%+28.5%

Cumulative growth

Daily Returns

Daily percentage return beside SPXU.

Daily Out/Under-Performance

Portfolio return minus SPXU return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × SPXU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded SPXU wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling